In conclusion, we believe that our findings add a novel tile in the puzzle of NF-κB-addicted thyroid cancer and that D6/ACKR2 and miR-146a are promising targets for new therapeutical strategies in fighting ATC. This evidence concerns the gene NFKB1 and thyroid cancer.